RedHill Biopharma is dedicated to the development and commercialization in the U.S. of proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases, including cancer



Commercial Products

RedHill has assembled an experienced specialty GI commercial team, with a proven track-record, to lead its U.S. commercial operations, headquartered in Raleigh, NC. RedHill currently promotes  two gastrointestinal specialty products in select U.S. territories: 

Donnatal® (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide) - a prescription oral adjunctive drug used in the treatment of IBS and acute enterocolitis.

EnteraGam® - a medical food intended for the dietary management of chronic diarrhea and loose stools


Development Pipeline 

RedHill's pipeline of  late-stage, proprietary development programs includes three Phase III programs for gastrointestinal disease, as well as several Phase II programs in oncology and gastrointestinal diseases. 


Please see RedHill Biopharma's expanded acceess policy here.